Issue: December 2018
December 11, 2018
1 min read
Save
This article is more than 5 years old. Information may no longer be current.
EWTOPIA75
Issue: December 2018
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Assessment of ezetimibe on the prevention of cerebrovascular and CV events in patients aged 75 years or older with middle to high risk and elevated LDL